Ordinary Rebalance | Solactive Global Vaccination Index | Effective Date 13th November 2023
In the ordinary rebalance, the following composition will be implemented effective open 13.11.2023:
ASTRAZENECA PLC |
BAVARIAN NORDIC A/S |
BIONTECH SE |
CUREVAC BV |
DYNAVAX TECHNOLOGIES CORP |
EQRX INC |
GILEAD SCIENCES INC |
GRIFOLS SA CLASS A |
GSK PLC |
IMMUNITYBIO INC |
JOHNSON & JOHNSON |
LABORATORY CRP OF AMER HLDGS |
MERCK & CO. INC. |
MODERNA INC |
PFIZER INC |
REGENERON PHARMACEUTICALS |
ROIVANT SCIENCES LTD |
SANOFI SA |
VAXCYTE INC |
VIR BIOTECHNOLOGY INC |